Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2026-02-13

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$875.2m reported value +31.4% vs Q3 2025
33positions
47.3%in top 10
12 new 8 added 10 reduced 8 sold out vs Q3 2025

Holdings, Q4 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ABIVAX SA SPONSORED ADS ABVX ABVX 381,233 $51.4m5.87% 5.87% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 291.8k, Q4 2025 381.2k +89.4k +89,413 30.6%
2 REVOLUTION MEDICINES INC COM RVMD RVMD 638,385 $50.8m5.81% 5.81% ReducedShares held: Q1 2025 340.1k, Q2 2025 415.6k, Q3 2025 643.0k, Q4 2025 638.4k -4.7k -4,665 -0.7%
3 INSMED INC COM PAR $.01 INSM INSM 264,293 $46.0m5.26% 5.26% ReducedShares held: Q1 2025 401.6k, Q2 2025 372.7k, Q3 2025 319.8k, Q4 2025 264.3k -55.5k -55,480 -17.4%
4 BRIDGEBIO PHARMA INC COM BBIO BBIO 595,473 $45.5m5.20% 5.20% AddedShares held: Q1 2025 656.7k, Q2 2025 551.7k, Q3 2025 589.7k, Q4 2025 595.5k +5.7k +5,744 1.0%
5 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 481,564 $38.0m4.35% 4.35% ReducedShares held: Q1 2025 503.0k, Q2 2025 527.5k, Q3 2025 570.6k, Q4 2025 481.6k -89.0k -89,005 -15.6%
6 AXSOME THERAPEUTICS INC COM AXSM AXSM 206,921 $37.8m4.32% 4.32% AddedShares held: Q1 2025 118.2k, Q2 2025 144.4k, Q3 2025 152.6k, Q4 2025 206.9k +54.3k +54,307 35.6%
7 NUVALENT INC COM COM 368,697 $37.1m4.24% 4.24% ReducedShares held: Q1 2025 331.9k, Q2 2025 320.8k, Q3 2025 394.8k, Q4 2025 368.7k -26.1k -26,057 -6.6%
8 XENON PHARMACEUTICALS INC COM XENE XENE 799,743 $35.8m4.10% 4.10% UnchangedShares held: Q1 2025 683.5k, Q2 2025 660.6k, Q3 2025 799.7k, Q4 2025 799.7k
9 APOGEE THERAPEUTICS INC COM COM 474,839 $35.8m4.10% 4.10% AddedShares held: Q1 2025 229.7k, Q2 2025 311.5k, Q3 2025 402.8k, Q4 2025 474.8k +72.0k +72,028 17.9%
10 TERNS PHARMACEUTICALS INC COM COM 872,049 $35.2m4.03% 4.03% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 872.0k
11 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 893,473 $31.3m3.58% 3.58% AddedShares held: Q1 2025 0, Q2 2025 521.1k, Q3 2025 717.0k, Q4 2025 893.5k +176.5k +176,502 24.6%
12 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 63,580 $31.0m3.54% 3.54% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 85.3k, Q4 2025 63.6k -21.7k -21,738 -25.5%
13 VERA THERAPEUTICS INC CL A VERA VERA 601,774 $30.5m3.48% 3.48% AddedShares held: Q1 2025 623.6k, Q2 2025 309.7k, Q3 2025 354.5k, Q4 2025 601.8k +247.2k +247,245 69.7%
14 COGENT BIOSCIENCES INC COM COGT COGT 824,283 $29.3m3.35% 3.35% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 824.3k
15 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 131,808 $28.1m3.21% 3.21% ReducedShares held: Q1 2025 113.3k, Q2 2025 134.7k, Q3 2025 146.3k, Q4 2025 131.8k -14.5k -14,483 -9.9%
16 GUARDANT HEALTH INC COM GH GH 271,685 $27.7m3.17% 3.17% NewShares held: Q1 2025 315.7k, Q2 2025 302.3k, Q3 2025 0, Q4 2025 271.7k
17 ROIVANT SCIENCES LTD SHS ROIV ROIV 1,186,817 $25.8m2.94% 2.94% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 959.7k, Q4 2025 1.2m +227.1k +227,114 23.7%
18 IDEAYA BIOSCIENCES INC COM IDYA IDYA 723,653 $25.0m2.86% 2.86% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 723.7k
19 VIRIDIAN THERAPEUTICS INC COM VRDN VRDN 690,528 $21.5m2.46% 2.46% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 690.5k
20 FULCRUM THERAPEUTICS INC COM FULC FULC 1,892,683 $21.4m2.45% 2.45% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 1.9m
21 CYTOKINETICS INC COM NEW CYTK CYTK 325,668 $20.7m2.36% 2.36% AddedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 254.8k, Q4 2025 325.7k +70.9k +70,873 27.8%
22 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 459,727 $20.3m2.31% 2.31% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 459.7k
23 ARGENX SE SPONSORED ADR ARGX ARGX 23,256 $19.6m2.23% 2.23% ReducedShares held: Q1 2025 41.9k, Q2 2025 44.0k, Q3 2025 38.8k, Q4 2025 23.3k -15.5k -15,511 -40.0%
24 NATERA INC COM NTRA NTRA 80,875 $18.5m2.12% 2.12% UnchangedShares held: Q1 2025 139.9k, Q2 2025 118.1k, Q3 2025 80.9k, Q4 2025 80.9k
25 ORIC PHARMACEUTICALS INC COM ORIC ORIC 2,010,307 $16.4m1.88% 1.88% ReducedShares held: Q1 2025 2.0m, Q2 2025 2.0m, Q3 2025 2.2m, Q4 2025 2.0m -149.2k -149,167 -6.9%
26 KYMERA THERAPEUTICS INC COM KYMR KYMR 206,445 $16.1m1.84% 1.84% ReducedShares held: Q1 2025 0, Q2 2025 0, Q3 2025 277.7k, Q4 2025 206.4k -71.3k -71,281 -25.7%
27 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 146,303 $15.7m1.79% 1.79% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 146.3k
28 OLEMA PHARMACEUTICALS INC COM OLMA OLMA 617,714 $15.4m1.76% 1.76% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 617.7k
29 ARCUS BIOSCIENCES INC COM RCUS RCUS 565,142 $13.5m1.54% 1.54% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 565.1k
30 DISC MEDICINE INC COM IRON IRON 153,206 $12.2m1.39% 1.39% ReducedShares held: Q1 2025 0, Q2 2025 299.5k, Q3 2025 397.7k, Q4 2025 153.2k -244.5k -244,487 -61.5%
31 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 35,749 $10.5m1.20% 1.20% NewShares held: Q1 2025 71.8k, Q2 2025 0, Q3 2025 0, Q4 2025 35.7k
32 UNIQURE NV SHS QURE QURE 321,655 $7.7m0.88% 0.88% NewShares held: Q1 2025 0, Q2 2025 0, Q3 2025 0, Q4 2025 321.7k
33 MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD MLTX MLTX 262,643 $3.5m0.40% 0.40% UnchangedShares held: Q1 2025 179.2k, Q2 2025 0, Q3 2025 262.6k, Q4 2025 262.6k

Sold out since Q3 2025

SecurityTickerShares held beforeValue then
MERUS N V MRUS MRUS 372,022 $35.0m372.0k shares
ARCELLX INC ACLX ACLX 313,733 $25.8m313.7k shares
NEUROCRINE BIOSCIENCES INC NBIX NBIX 181,897 $25.5m181.9k shares
AKERO THERAPEUTICS INC AKRO AKRO 397,010 $18.9m397.0k shares
ENLIVEN THERAPEUTICS INC ELVN ELVN 783,411 $16.0m783.4k shares
JANUX THERAPEUTICS INC JANX JANX 639,699 $15.6m639.7k shares
ADMA BIOLOGICS INC ADMA ADMA 808,673 $11.9m808.7k shares
HARROW INC HROW HROW 160,234 $7.7m160.2k shares